You are here: Industry Insights > COVID-19 vaccine

News List

First patient dosed with COVID-19 vaccine using self-amplifying RNA europeanpharmaceuticalreview
June 28, 2020
A Phase I clinical trial to test Imperial College London’s COVID-19 vaccine candidate has been initiated, with the first patient dosed.
Oxford Covid-19 vaccine doses improve immune response in animals pharmaceutical-technology
June 28, 2020
A study conducted by the Pirbright Institute, in alliance with the University of Oxford, has demonstrated that two doses of the ChAdOx1 nCoV-19 (AZD1222) Covid-19 vaccine boost antibody response in pigs, compared to a single dose.
Japan’s Daiichi Sankyo in talks with AstraZeneca for Covid-19 vaccine pharmaceutical-technology
June 28, 2020
Japanese pharmaceutical company Daiichi Sankyo has entered an agreement for discussions with AstraZeneca for the supply of a Covid-19 vaccine candidate, being developed in alliance with the University of Oxford, in Japan.
Sanofi and Translate Bio Expand Vaccine Collaboration contractpharma
June 28, 2020
To develop mRNA vaccines across all infectious disease areas in a deal potentially worth up to $1.9 billion.
Moderna and Catalent announce collaboration for COVID-19 vaccine candidate expresspharma
June 28, 2020
Catalent to provide vial filling and packaging capacity, as well as additional staffing to support the production of an initial 100 million doses of the vaccine candidate from its facility in Bloomington, Indiana in the US.
Tonix Pharmaceuticals and Southern Research COVID-19 vaccine provides a novel vector expresspharma
June 28, 2020
As horsepox virus may have been accidentally extirpated there has most likely been no previous exposure to the vector, and any vaccine administered based on it is unlikely to encounter already-present neutralising antibodies.
UK researchers form consortium to monitor Covid-19 vaccines pharmaceutical-technology
June 24, 2020
The University of Dundee’s Medicines Monitoring Unity (MEMO Research) and the Drug Safety Research Unit (DSRU) in the UK have formed a consortium to track the safety and effectiveness of Covid-19 vaccines.
Sanofi eyes approval of COVID-19 vaccine by first half of 2021 expresspharma
June 24, 2020
Sanofi, which is hosting a virtual research and development event, and GSK had said in April the vaccine, if successful, would be available in the second half of 2021.
Indian ancillary manufacturers assure uninterrupted supply of materials related to COVID-19 vaccine expresspharma
June 24, 2020
In the recent past, many, globally and in India, had raised concerns about a potential shortage of ancillary supplies to distribute the vaccine, after development.
GSK/Clover's COVID-19 vaccine moves into human trials pharmatimes
June 23, 2020
GSK’s scientific collaboration with Chinese biotech Clover Pharmaceuticals to develop an adjuvanted COVID-19 vaccine is now being tested in human clinical trials.

Previous page 1 2 3 4 5 6 7 8 9 10 ... 116 117 Next page